Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3311
+0.0011 (0.33%)
At close: Jun 27, 2025, 4:00 PM
0.3232
-0.0079 (-2.39%)
After-hours: Jun 27, 2025, 7:01 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $20.58 million as of June 27, 2025. Its market cap has decreased by -73.08% in one year.
Market Cap
20.58M
Enterprise Value
-17.66M
1-Year Change
-73.08%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $20.58M, a decrease of -97.85%. That is a compound annual growth rate of -51.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 24.27M | -30.72% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |